These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30268922)

  • 1. Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis.
    Ter Veer E; van Kleef JJ; Schokker S; van der Woude SO; Laarman M; Haj Mohammad N; Sprangers MAG; van Oijen MGH; van Laarhoven HWM
    Eur J Cancer; 2018 Nov; 103():214-226. PubMed ID: 30268922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis.
    van den Ende T; Ter Veer E; Mali RMA; van Berge Henegouwen MI; Hulshof MCCM; van Oijen MGH; van Laarhoven HWM
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31013858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study.
    van Kleef JJ; Dijksterhuis WPM; van den Boorn HG; Prins M; Verhoeven RHA; Gisbertz SS; Slingerland M; Mohammad NH; Creemers GJ; Neelis KJ; Heisterkamp J; Rosman C; Ruurda JP; Kouwenhoven EA; van de Poll-Franse LV; van Oijen MGH; Sprangers MAG; van Laarhoven HWM;
    Gastric Cancer; 2021 Nov; 24(6):1203-1212. PubMed ID: 34251543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis.
    Mohammad NH; ter Veer E; Ngai L; Mali R; van Oijen MG; van Laarhoven HW
    Cancer Metastasis Rev; 2015 Sep; 34(3):429-41. PubMed ID: 26267802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuation of trastuzumab beyond progression in HER2-positive advanced esophagogastric cancer: a meta-analysis.
    Ter Veer E; van den Ende T; Creemers A; de Waal L; van Oijen MGH; van Laarhoven HWM
    Acta Oncol; 2018 Dec; 57(12):1599-1604. PubMed ID: 30264641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.
    Haj Mohammad N; Bernards N; van Putten M; Lemmens VEPP; van Oijen MGH; van Laarhoven HWM
    Eur J Cancer; 2017 Jun; 78():28-36. PubMed ID: 28412586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.
    Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Jensen K;
    Cochrane Database Syst Rev; 2013 May; (5):CD008107. PubMed ID: 23728671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.
    Chau I; Norman AR; Cunningham D; Waters JS; Oates J; Ross PJ
    J Clin Oncol; 2004 Jun; 22(12):2395-403. PubMed ID: 15197201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
    Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulvestrant for hormone-sensitive metastatic breast cancer.
    Lee CI; Goodwin A; Wilcken N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011093. PubMed ID: 28043088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; Caron HN; van Dalen EC
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends.
    Edwards P; Davidson M; Calamai V; Cunningham D; Starling N
    Cancer Treat Rev; 2018 Dec; 71():32-38. PubMed ID: 30343173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials.
    Bando H; Rubinstein L; Harris P; Yoshino T; Doi T; Ohtsu A; Welch J; Takebe N
    Gastric Cancer; 2017 May; 20(3):481-488. PubMed ID: 27510411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma.
    Wen J; Bedford M; Begum R; Mitchell H; Hodson J; Whiting J; Griffiths E
    J Surg Oncol; 2018 Jun; 117(8):1697-1707. PubMed ID: 29761518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.
    Wu PA; Huang V; Bigby ME
    Br J Dermatol; 2014 May; 170(5):1015-20. PubMed ID: 24841586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis.
    Luksanapruksa P; Buchowski JM; Hotchkiss W; Tongsai S; Wilartratsami S; Chotivichit A
    Spine J; 2017 May; 17(5):689-708. PubMed ID: 27988342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
    BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.